Site icon Making the Rounds

Blood Pressure Control and Mortality Among US Veterans

Article: Blood Pressure Control and Mortality Among US Veterans

Authors: Masaaki Yamada, Benjamin R Griffin, Qianyi Shi, Meenakshi Sambharia, Melissa L Swee, Mary K Good, Korey Kennelty, Elissa Faro, Heather S Reisinger, Saket Girotra, Brian C Lund, Mary S Vaughan Sarrazin, Diana I Jalal

Journal: Hypertension. 2026 Jun;83(6):e25787.

Abstract:
Background: Intensive blood pressure (BP) control reduces mortality and cardiovascular disease in clinical trials. However, real-world BP measurements often differ from standardized protocols. We evaluated the impact of real-world systolic BP on mortality among US Veterans.

Methods: We conducted a retrospective cohort study of Veterans with hypertension, defined by diagnostic codes, antihypertensive prescriptions, or ≥2 office BP readings ≥130/90 mm Hg in 2016 to 2017, with follow-up through March 2021. Systolic BP was treated as a time-dependent covariate and categorized into 7 groups: <110, 110-119, 120-129, 130-139, 140-149, 150-159, and ≥160 mm Hg. Discrete-time survival models assessed associations with all-cause mortality, adjusting for demographics, body mass index, and comorbidities. Stratified analyses were conducted based on cardiovascular disease and chronic kidney disease status.

Results: Among >2.3 million Veterans (mean age, 66 years; 36% with diabetes; 22% with cardiovascular disease; and 19% with chronic kidney disease), the lowest mortality risk was observed in those with systolic BP of 130 to 139 mm Hg. In this cohort, adjusted hazard ratios for all-cause mortality per year in each systolic BP category were 1.29 for BP <110; 1.03 for BP 110 to 119; 0.88 for BP 120 to 129; 0.83 for BP 130 to 139; 0.86 for BP 140 to 149; and 0.89 for BP 150 to 159 mm Hg, compared with a year with BP ≥160 mm Hg. These associations remained consistent across cardiovascular disease and chronic kidney disease subgroups.

Conclusions: Veterans with routine systolic BP of 130 to 139 mm Hg had the lowest mortality. These findings suggest that a higher BP target may be appropriate in clinical practice, especially for older adults with comorbidities.

Link to journal online: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.125.25787

Exit mobile version